Skip to main content
Home > SciBX on Science > Therapeutics

Chronological Index of SciBX: The Science-Business eXchange: Therapeutics

SciBX: The Science-Business eXchange Current Issue
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Bladder cancer Keratin 14 (KRT14) Patient sample studies suggest KRT14 could help predict bladder cancer …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer IL-20 Studies in mice and in human samples suggest inhibiting IL-20 could help treat breast …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Lymphocyte-activation gene 3 (LAG3; CD223); PD-1 receptor (PDCD1; PD-1; CD279) Mouse studies suggest…

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Wingless-type MMTV integration site family member 3A (WNT3A); BRAF Mouse studies suggest …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Retinoblastoma Spleen tyrosine kinase (SYK) Patient sample and mouse studies suggest inhibiting SYK could …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Ischemia/reperfusion injury Fibroblast growth factor 2 (FGF2); syndecan 4 (SDC4) Rat …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Genitourinary disease Incontinence Muscarinic acetylcholine receptor M3 (CHRM3; HM3) In vitro and rat studies …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Drug-induced liver toxicity (DILI) Gap junction protein b1, 32 kDa (GJB1; CX32; connexin-32) Mouse…

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Liver disease IL-11 receptor In vitro and mouse studies suggest agonizing the IL-11 receptor could…

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Pneumonia Growth hormone-releasing hormone receptor (GHRHR) Mouse studies suggest GHRHR …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Pseudomonas Toll-like receptor 5 (TLR5); IL-1b Cell culture studies suggest agonizing TLR5 and …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Muscular dystrophy MicroRNA-21 (miR-21) Patient sample and mouse studies suggest …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) AMP-activated protein kinase (AMPK) Cell culture studies suggest …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression Microtubule-associated protein 2 (MAP2) Studies in mice identified a pregnenolone derivative …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Nerve damage Acetylcholinesterase (AChE); butyrylcholinesterase (BuChE) Studies in vitro and in mice …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Other Hearing loss Phosphodiesterase-5 (PDE-5) Rodent studies suggest PDE-5 inhibitors could help prevent or treat…

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Acute lung injury Chemokine CC motif ligand 5 (RANTES; CCL5); platelet factor 4 (PF4; CXCL4) …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Renal disease Kelch-like 3 (KLHL3); cullin 3 (CUL3); solute carrier family 12 potassium-chloride …

    Published on 2/2/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Inflammation; sepsis Rhomboid 5 homolog 2 (RHBDF2; iRhom2) Studies in cell culture and in mice suggest …

    Published on 2/2/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute lymphoblastic leukemia (ALL) Not applicable Genomewide association studies …

    Published on 1/26/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer N-Methylpurine-DNA glycosylase (MPG; APNG) A study in cells and in …

    Published on 1/26/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Smoothened (SMO) In vitro studies identified an oxysterol-binding site on …

    Published on 1/26/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Chronic myelogenous leukemia (CML) CD27; CD70 (CD27L) Cell culture and mouse …

    Published on 1/26/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Acyl-CoA synthetase long-chain family member 1 (…

    Published on 1/26/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Netrin 1 (NTN1) Studies in mice and in human …

    Published on 1/26/2012

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or have never received a password, please go here and ask us to send you a new one.

SciBX: Science-Business eXchange

BioCentury's weekly translational science journal, published in collaboration with Nature Publishing Group:

  • Selects from hundreds of scientific papers published each week to identify early opportunities for investment, alliances and partnerships
  • Reports on the most commercially relevant developments